201 related articles for article (PubMed ID: 20641116)
1. Use of guideline-recommended therapies for heart failure in the Medicare population.
DiMartino LD; Shea AM; Hernandez AF; Curtis LH
Clin Cardiol; 2010 Jul; 33(7):400-5. PubMed ID: 20641116
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
3. Outpatient management of heart failure in the United States, 2006-2008.
Mosalpuria K; Agarwal SK; Yaemsiri S; Pierre-Louis B; Saba S; Alvarez R; Russell SD
Tex Heart Inst J; 2014 Jun; 41(3):253-61. PubMed ID: 24955039
[TBL] [Abstract][Full Text] [Related]
4. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
5. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
6. Utilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims database.
Kim JY; Kim HJ; Jung SY; Kim KI; Song HJ; Lee JY; Seong JM; Park BJ
BMC Cardiovasc Disord; 2012 Jul; 12():60. PubMed ID: 22849621
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
8. Lack of improvement in outpatient management of congestive heart failure in the United States.
Banerjee D; Stafford RS
Arch Intern Med; 2010 Aug; 170(15):1399-400. PubMed ID: 20696970
[No Abstract] [Full Text] [Related]
9. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
Tjia J; Briesacher BA
J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
[TBL] [Abstract][Full Text] [Related]
11. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
12. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
13. ACE up the sleeve - are vascular patients medically optimized?
Coveney AP; O'Brien GC; Fulton GJ
Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909
[TBL] [Abstract][Full Text] [Related]
14. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients.
Conrad N; Judge A; Canoy D; Tran J; O'Donnell J; Nazarzadeh M; Salimi-Khorshidi G; Hobbs FDR; Cleland JG; McMurray JJV; Rahimi K
PLoS Med; 2019 May; 16(5):e1002805. PubMed ID: 31112552
[TBL] [Abstract][Full Text] [Related]
16. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis.
Richardson DM; Bain KT; Diamond JJ; Novielli KD; Lee SP; Goldfarb NI
Drugs Aging; 2010 Oct; 27(10):845-54. PubMed ID: 20883064
[TBL] [Abstract][Full Text] [Related]
18. Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study.
Bitar S; Agrinier N; Alla F; Rossignol P; Mebazaa A; Thilly N
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1489-1500. PubMed ID: 31339629
[TBL] [Abstract][Full Text] [Related]
19. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
[TBL] [Abstract][Full Text] [Related]
20. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
Guo JD; Liu GG; Christensen DB; Fu AZ
Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
